I hope its helpful
The global increase in the prevalence of CKD is linked to the increasing prevalence of traditional risk factors, including obesity, hypertension, and diabetes mellitus, as well as metabolic factors, particularly insulin resistance, dyslipidemia, and hyperuricemia
pH-temperature responsive hydrogel-mediated delivery of exendin-4 encapsulated chitosan nanospheres for sustained therapeutic efficacy in type 2 diabetes mellitus
The coordination of membrane fission and fusion at the end of autophagosome maturation
Data Sharing Statement The datasets analyzed during the current study are available from the TriNetX research network but restrictions apply to the availability of these data
Regulatory bodies approved GLP-1 receptor agonists are TRULICITY (dulaglutide), BYETTA/BYDUREON (exenatide), VICTOZA (liraglutide), OZEMPIC/WEGOVY/RYBELSUS, (Semaglutide), MOUNJARO/ZEPBOUND (tirzepatide) and others